 

Active ingredient: Amoxicillin 

 

Form/Route: Oral Suspension/Oral 

 

Recommended studies: 2 studies 

 

1. Type of study: Fasting 


Design: Single-dose, two-way crossover in vivo 

Strength: 400 mg/ 5 mL 

Subjects: Healthy males and nonpregnant females, general population. 

 

 

2. Type of study: Fed 


Design: Single-dose, two-way crossover in vivo 

Strength: 400 mg/ 5 mL 

Subjects: Healthy males and nonpregnant females, general population. 

 

 

Analytes to measure (in appropriate biological fluid): Amoxicillin in plasma 

 

Bioequivalence based on (90% CI): Amoxicillin 

 

Waiver request of in vivo testing: 200 mg/5 mL based on (i) acceptable bioequivalence studies 
on the 400 mg/5 mL strength, (ii) acceptable in vitro dissolution testing of all strengths, and (iii) 
proportional similarity of the formulations across all strengths. 

 

Dissolution test method and sampling times: 

 

Please note that a Dissolution Methods Database is available to the public at the OGD website 
at http://www.accessdata.fda.gov/scripts/cder/dissolution/. Please find the dissolution 
information for this product at this website. Please conduct comparative dissolution testing on 12 
dosage units each of all strengths of the test and reference products. Specifications will be 
determined upon review of the application. 

 

 


